Trial Profile
Pharmacodynamic study of sugammadex in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Pharmacodynamics
- 01 Dec 2015 New trial record